Vir Biotechnology Inc (VIR) Annual Income Statement (USD)
VIR Quarterly Financials (USD)
Frequently Asked Questions About Vir Biotechnology Inc (VIR) Stock
Vir Biotechnology Inc's (VIR) last reported annual revenue was USD 86.18 Million.
Vir Biotechnology Inc's (VIR) annual revenue growth rate based on the revenue reported in the past 5 years is : 150.83%
Vir Biotechnology Inc's(VIR) is not profitable as of its last reported annual financials.
The net profit margin for Vir Biotechnology Inc's(VIR) from its laster reported year is -713.69%
The return on equity (ROE) for Vir Biotechnology Inc's(VIR) from its last reported annual financials is : -30.67%
The return on assets (ROA) for Vir Biotechnology Inc's(VIR) from its last reported annual financials is : -16.73%
The return on invested capital (ROIC) for Vir Biotechnology Inc's(VIR) from its last reported annual financials is : -35.33%
The Debt to Equity ratio for Vir Biotechnology Inc's(VIR) from its last reported annual financials is : 0.00%
The dividend yield for Vir Biotechnology Inc's(VIR) from its laster reported year is 0.00%
Vir Biotechnology Inc's(VIR) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for VIR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
